Last reviewed · How we verify
Trimetrexate Toxicity
Approved treatments
- Wellcovorin · Pfizer Japan Inc
- Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Trimetrexate Toxicity patent landscape — cliff calendar, originator estates, attackable patents
- Trimetrexate Toxicity treatment landscape brief
- Trimetrexate Toxicity treatment updates RSS
Frequently asked questions about Trimetrexate Toxicity
What drugs treat Trimetrexate Toxicity?
Tracked treatments include Wellcovorin, Fusilev.
What is the treatment for Trimetrexate Toxicity?
Standard treatment for Trimetrexate Toxicity includes Wellcovorin, Fusilev. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Trimetrexate Toxicity patent cliff · Trimetrexate Toxicity CI report
- Treatment: Wellcovorin · Pfizer Japan Inc
- Treatment: Fusilev · Spectrum Pharms
- Treatment: Fusilev · Acrotech Biopharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing